BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34732818)

  • 1. miRNA-200c-3p targets talin-1 to regulate integrin-mediated cell adhesion.
    Obeng G; Park EJ; Appiah MG; Kawamoto E; Gaowa A; Shimaoka M
    Sci Rep; 2021 Nov; 11(1):21597. PubMed ID: 34732818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-200c-3p regulates α4 integrin-mediated T cell adhesion and migration.
    Mokmued K; Obeng G; Kawamoto E; Caidengbate S; Leangpanich S; Akama Y; Gaowa A; Shimaoka M; Park EJ
    Exp Cell Res; 2024 Jun; ():114146. PubMed ID: 38936759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of Talin-1 is associated with the increased expression of miR-182-5p and miR-9-5p in coronary artery disease.
    Gholipour A; Shakerian F; Zahedmehr A; Irani S; Mowla SJ; Malakootian M
    J Clin Lab Anal; 2022 Apr; 36(4):e24252. PubMed ID: 35156729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Talin variant P229S compromises integrin activation and associates with multifaceted clinical symptoms.
    Azizi L; Varela L; Turkki P; Mykuliak VV; Korpela S; Ihalainen TO; Church J; Hytönen VP; Goult BT
    Hum Mol Genet; 2022 Dec; 31(24):4159-4172. PubMed ID: 35861643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of promyelocytic leukemia zinc finger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down-regulation of integrin α3β4.
    Dahal S; Chaudhary P; Kim JA
    Cell Oncol (Dordr); 2023 Aug; 46(4):1113-1126. PubMed ID: 36995683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downexpression of miR-200c-3p Contributes to Achalasia Disease by Targeting the
    Micale L; Fusco C; Nardella G; Palmieri O; Latiano T; Gioffreda D; Tavano F; Panza A; Merla A; Biscaglia G; Gentile M; Cuttitta A; Castori M; Perri F; Latiano A
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of talin with the cell membrane is essential for integrin activation and focal adhesion formation.
    Chinthalapudi K; Rangarajan ES; Izard T
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10339-10344. PubMed ID: 30254158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1.
    Tang H; Yao L; Tao X; Yu Y; Chen M; Zhang R; Xu C
    Int J Mol Med; 2013 Aug; 32(2):381-8. PubMed ID: 23722670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process.
    Wang HY; Liu YN; Wu SG; Hsu CL; Chang TH; Tsai MF; Lin YT; Shih JY
    Cancer Biomark; 2020; 28(3):351-363. PubMed ID: 32417760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB3 promotes the proliferation and metastasis of glioblastoma and is negatively regulated by miR-200b-3p and miR-200c-3p.
    Liu J; Wang L; Li X
    Cell Biochem Funct; 2018 Oct; 36(7):357-365. PubMed ID: 30232806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NPIY motif in the integrin beta1 tail dictates the requirement for talin-1 in outside-in signaling.
    Nieves B; Jones CW; Ward R; Ohta Y; Reverte CG; LaFlamme SE
    J Cell Sci; 2010 Apr; 123(Pt 8):1216-26. PubMed ID: 20332112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Talin-dependent integrin activation is required for endothelial proliferation and postnatal angiogenesis.
    Pulous FE; Carnevale JC; Al-Yafeai Z; Pearson BH; Hamilton JAG; Henry CJ; Orr AW; Petrich BG
    Angiogenesis; 2021 Feb; 24(1):177-190. PubMed ID: 33113074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of mouse cardiomyocyte talin-1 and talin-2 leads to β-1 integrin reduction, costameric instability, and dilated cardiomyopathy.
    Manso AM; Okada H; Sakamoto FM; Moreno E; Monkley SJ; Li R; Critchley DR; Ross RS
    Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6250-E6259. PubMed ID: 28698364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of microRNA-200c-3p alleviates the aggravation of venous thromboembolism by targeting serpin family C member 1.
    Jian X; Yang D; Wang L; Wang H
    Bioengineered; 2021 Dec; 12(2):11156-11168. PubMed ID: 34783290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal miR-200c-3p negatively regulates the migraion and invasion of lipopolysaccharide (LPS)-stimulated colorectal cancer (CRC).
    Jiang Y; Ji X; Liu K; Shi Y; Wang C; Li Y; Zhang T; He Y; Xiang M; Zhao R
    BMC Mol Cell Biol; 2020 Jun; 21(1):48. PubMed ID: 32600257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA PTPRG Antisense RNA 1 Reduces Radiosensitivity of Nonsmall Cell Lung Cancer Cells Via Regulating MiR-200c-3p/TCF4.
    Ma Q; Niu R; Huang W; Da L; Tang Y; Jiang D; Xi Y; Zhang C
    Technol Cancer Res Treat; 2020; 19():1533033820942615. PubMed ID: 33174523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Talin and signaling through integrins.
    Bouaouina M; Harburger DS; Calderwood DA
    Methods Mol Biol; 2012; 757():325-47. PubMed ID: 21909921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1.
    Maolakuerban N; Azhati B; Tusong H; Abula A; Yasheng A; Xireyazidan A
    Cancer Biol Ther; 2018 Apr; 19(4):282-291. PubMed ID: 29394133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-200c-3p increased HDMEC proliferation through the notch signaling pathway.
    Hu X; Bai S; Li L; Tian P; Wang S; Zhang N; Shen B; Du J; Liu S
    Exp Biol Med (Maywood); 2021 Apr; 246(8):897-905. PubMed ID: 33472424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements.
    Schwickert A; Weghake E; Brüggemann K; Engbers A; Brinkmann BF; Kemper B; Seggewiß J; Stock C; Ebnet K; Kiesel L; Riethmüller C; Götte M
    PLoS One; 2015; 10(12):e0143993. PubMed ID: 26657485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.